0000000000366846

AUTHOR

A Stevanovic

showing 2 related works from this author

Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Reg…

2019

Aims In recent years, stroke prevention in patients with atrial fibrillation (AF) has radically changed, with increasing use of non-vitamin K antagonist oral anticoagulants (NOACs). Contemporary European data on AF thromboprophylaxis are needed. Methods and results We report 1-year follow-up data from the EURObservational Research Programme in Atrial Fibrillation (EORP-AF) General Long-Term Registry. Outcomes were assessed according to antithrombotic therapy. At 1-year follow-up, 9663 (88.0%) patients had available data for analysis: 586 (6.1%) were not treated with any antithrombotic; 681 (7.0%) with antiplatelets only; 4066 (42.1%) with vitamin K antagonist (VKA) only; 3167 (32.8%) with …

AdultMaleAcute coronary syndromemedicine.medical_specialtymedicine.drug_classHemorrhageOutcomes030204 cardiovascular system & hematologyLower riskRisk Assessment[SHS]Humanities and Social Sciences03 medical and health sciences0302 clinical medicineFibrinolytic AgentsRisk FactorsPhysiology (medical)Internal medicineCause of DeathAntithromboticMedicineHumans030212 general & internal medicineProspective StudiesRegistriesPractice Patterns Physicians'StrokeAgedEORP-AF registryAged 80 and overAntithrombotic therapybusiness.industryProportional hazards modelAtrial fibrillationVitamin K antagonistMiddle Agedmedicine.diseaseAtrial fibrillationObservational registriesEuropeStrokeFemaleCardiology and Cardiovascular MedicinebusinessAntithrombotic therapy; Atrial fibrillation; EORP-AF registry; Observational registries; Outcomes; StrokeFibrinolytic agentFollow-Up Studies
researchProduct

Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research

2017

Executive summary A concerted effort to tackle the global health problem posed by traumatic brain injury (TBI) is long overdue. TBI is a public health challenge of vast, but insufficiently recognised, proportions. Worldwide, more than 50 million people have a TBI each year, and it is estimated that about half the world’s population will have one or more TBIs over their lifetime. TBI is the leading cause of mortality in young adults and a major cause of death and disability across all ages in all countries, with a disproportionate burden of disability and death occurring in low-income and middle-income countries (LMICs). It has been estimated that TBI costs the global economy approximately $…

medicine.medical_specialtyEVIDENCE-BASED MEDICINETreatment outcomePoison controlOther Research Radboud Institute for Molecular Life Sciences [Radboudumc 0]EMERGENCY-DEPARTMENT VISITSReviewPLACEBO-CONTROLLED TRIALMiddle income countryHealthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18]03 medical and health sciences0302 clinical medicineIntensive careBrain Injuries TraumaticJournal Articlemedicinetraumatic barin injuryHumans030212 general & internal medicineClinical careNeurologic diseasePsychiatryDIAGNOSTIC MANAGEMENT STRATEGIESbusiness.industryRANDOMIZED CONTROLLED-TRIALACUTE SUBDURAL-HEMATOMASEVERE HEAD-INJURYROAD TRAFFIC INJURIESbrain injuryHospital care3. Good healthReconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10]Brain InjuriesHealth care costPATIENT-REPORTED OUTCOMESHuman medicineNeurology (clinical)businessHumanities030217 neurology & neurosurgeryGLASGOW COMA SCALE
researchProduct